USA - New York Stock Exchange - NYSE:SONX - US8354311073 - Common Stock
The current stock price of SONX is 0.23 USD. In the past year, price decreased by -90.3%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.66 | 222.87B | ||
| ISRG | INTUITIVE SURGICAL INC | 67.23 | 207.51B | ||
| BSX | BOSTON SCIENTIFIC CORP | 34.36 | 150.19B | ||
| SYK | STRYKER CORP | 28.48 | 143.40B | ||
| IDXX | IDEXX LABORATORIES INC | 60.8 | 61.33B | ||
| BDX | BECTON DICKINSON AND CO | 13.56 | 56.03B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.78 | 50.38B | ||
| RMD | RESMED INC | 25.84 | 37.33B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.42 | 36.42B | ||
| DXCM | DEXCOM INC | 33.17 | 24.19B | ||
| PODD | INSULET CORP | 71.96 | 23.13B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 12 | 19.23B |
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.
SONENDO INC
26061 Merit Circle, Suite 102
Laguna Hills CALIFORNIA US
CEO: Bjarne Bergheim
Employees: 244
Phone: 18447663636.0
Sonendo, Inc. is a medical technology company that has developed and is commercializing the GentleWave System to treat tooth decay. The company is headquartered in Laguna Hills, California and currently employs 244 full-time employees. The company went IPO on 2021-10-29. The Company’s Product segment includes the sales of the GentleWave System console and related accessories and instruments. The GentleWave System, is a technology platform designed to treat tooth decay by cleaning and disinfecting the microscopic spaces within teeth without the need to remove tooth structure. In addition to its GentleWave Console and single-use procedure instruments (PIs), it also offers ancillary products, such as SoundSeal and its Sonendo-branded liquid solution of ethylenediaminetetraacetic acid (EDTA). SoundSeal is a material used during the GentleWave Procedure to build and create a sealing platform on the top of the crown, which facilitates an airtight seal between the PI and the tooth. The Company’s Software segment includes the sales of its software licenses for practice management software to enable an integrated digital office for endodontists.
The current stock price of SONX is 0.23 USD. The price decreased by -4.33% in the last trading session.
SONX does not pay a dividend.
SONX has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SONX.
SONENDO INC (SONX) has a market capitalization of 12.48M USD. This makes SONX a Nano Cap stock.
The outstanding short interest for SONENDO INC (SONX) is 0% of its float.
ChartMill assigns a fundamental rating of 2 / 10 to SONX. SONX may be in some trouble as it scores bad on both profitability and health.
Over the last trailing twelve months SONX reported a non-GAAP Earnings per Share(EPS) of -0.65. The EPS increased by 72.34% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -68.96% | ||
| ROE | -161.08% | ||
| Debt/Equity | 0.98 |
9 analysts have analysed SONX and the average price target is 1.75 USD. This implies a price increase of 659.46% is expected in the next year compared to the current price of 0.23.
For the next year, analysts expect an EPS growth of 65.53% and a revenue growth 8.44% for SONX